Here, our investigation reveals a consistent up-regulation of ZNF692 in osteosarcoma, and establishes a noteworthy correlation between elevated ZNF692 expression and worse clinical prognosis in osteosarcoma patients. This evidence concerns the gene ZNF692 and osteosarcoma.